Margarita Beato-Sanchez - Publications

Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B-Cell Lymphoma Cell Lines.

Journal: Hematological oncology

Published: December 10, 2025

Splice-site mutations in POU2AF1 are associated with B-cell lymphomagenesis and therapeutic response.

Journal: Scientific reports

Published: June 30, 2025

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Journal: Cancers

Published: December 03, 2024

Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: November 23, 2023

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.

Journal: Frontiers in immunology

Published: September 13, 2023

A genetic profiling guideline to support diagnosis and clinical management of lymphomas.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 27, 2023

Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple Myeloma.

Journal: Cancers

Published: December 02, 2022

Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 24, 2022

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 21, 2022

An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy.

Journal: EJHaem

Published: January 20, 2022

Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial.

Journal: The Lancet. Haematology

Published: January 14, 2022

PD-1 loss and T-cell exhaustion in CTCL tumoral T cells.

Journal: Blood

Published: May 24, 2021